Atlas Trials

Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock

Clinical trial NCT05824767 · COMPLETED

Trial details

NCT number
NCT05824767
Sponsor
University of New Mexico
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Septic ShockVasodilatory Shock
Start date
2023-04-17
Primary completion
2025-03-12
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.